chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested Positive for COVID-19; Sick with COVID-19 symptoms; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested Positive for COVID-19) and ILLNESS (Sick with COVID-19 symptoms) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced ILLNESS (Sick with COVID-19 symptoms). On 22-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested Positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested Positive for COVID-19) and ILLNESS (Sick with COVID-19 symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: significant follow-up (events stop date has been updated)
Information has been received from a nurse referring to an unspecified number of unknown patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot#, expiration date and dose were unknown; oral). It was reported that the vaccine was improperly stored at 51.2 Fahrenheit for 23 minutes. There was no previous temperature excursion. Data logger was not involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccinee rec'd two boosters ("which may have been Engerix-B" indicates has not yet responded.
redness and swelling at the injection site; redness and swelling at the injection site; This spontaneous report was received from a consumer, referring to a 2-year-old male patient. The patient's pertinent medical history and concomitant medication were not reported. His concurrent conditions included penicillin allergy. No laboratory diagnostics or studies were performed.  On 25-OCT-2018, the patient was vaccinated with 1 shot (dose) of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (strength, vaccination scheme, anatomical site of injection, lot number and expiration date were not reported; route of administration was reported as injection) as prevention of measles, mumps and rubella (prophylaxis).  On 26-OCT-2018, the patient experienced redness and swelling at the injection site (vaccination site erythema and vaccination site swelling). It was reported that ice was given as a treatment for the adverse events and the patient did not seek medical attention. The reporter stated that the patient had not had any additional doses.  Therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was discontinued on 26-OCT-2018. The outcome of the events was reported as recovered. The causal relationship between the aforementioned events and therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.
Patient has a swollen and hard arm around the injection site and some redness and warm to the touch the last couple days since the date of shot.
Patient received smallpox at the site on Jan 08, 2019 to right arm, Presented this morning at the MC with multiple vesicles in various stages of break out and healing. Patient stated she removed dressing after smallpox was given and took a shower the day she received the vaccine. States she was not instructed not to remove dressing for 3 days or not to shower with smallpox vaccine site uncovered. Patient noted with cellulitis around vaccinated area. Seen by PA was placed on antibiotics. I instructed her on proper cleaning and dressing technique. Importance of keeping area clean and dry and proper hand washing.
On Monday 3/15 or Tuesday 3/16 I started developing a rash on the knuckles of my right hand and fingers. It first looked like small burns, and then started swelling to look more like spider bites. The rash spread over the course of the next two weeks, and also showed up on my left hand. Eventually, the one on my right hand looked like a blood blister. The rashes itched at first, and then started hurting to the touch. They were especially sensitive to sunlight. Now, as of 3/30, they seem to be clearing up.
Arm became sore and stiff within a couple hours and continued for about 2 days, within 24 hours began to feel chills and sweating (lasted about 12 hours), temperature was 99.7 during that time, 3 days in began to feel pain in head (sinuses, ear, jaw and lower teeth-all confined to the left side), neck on left side remains stiff, nose continues to run only on left side, all these symptoms come and go-they are not constant.
Pt recvd vax 1JUN92 & same day t105 w/brief febrile seizure;
10/21/2021- I started having joint pain in both thumbs, muscle spasm in my chest; 10/27/2021- Start having sharp right knee pain, went to see my doctor and was informed to give it time to see if the symptoms stop; 11/05/2021- Doctor referred me to pain management and was informed to take Ibuprofen to manage pain and inflammation.
Fever day # 1 of confluent maculopapular rash trunk/extremities.
Information has been received from a physician concerning a 9 month old male with an allergy to erythromycin ethylsuccinate (+) sulfisoxazole acetyl (Pediazole) and no other significant medical history, who on 02Jun03 was vaccinated with a 0.5ml IM dose of Hib conj vaccine (lot 643453/0645M). Concomitant vaccine included a dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid. There were no other medications. It was reported that the pt has had two incidences of immune thrombocytopenia purpura after receiving Hib conj vaccine. The pt was given immune globulin. It was reported that the pt was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow up information from a health professional indicated that two weeks after receiving Hib conj vaccine, on approx 16Jun03, the pt's platelet count was very critically low at 5 with petechiae all over. He was admitted to the hospital for about a week for treatment with gamma globulin and IV platelets. The diagnosis was ITP, idiopathic thrombocytopenic purpura. The pt has been hospitalized two more times with a platelet count out of range but not as low as previously. He was treated again with platelets on both of those admissions. He had his last dose of Hib conj vaccine (lot 649023/0368P) on 05May05 and his platelets were over 300,000 before that vaccination. They were down to 50,000 on 19Jul05. Additional information has been requested.
Worse thing I ever had ,,,4 times ,I had them After the high priced singles shot / the shot didn't help at all/Suspected Vaccination failure; Worse thing I ever had ,,,4 times, I had them / caused from stress; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient said worst thing he/she ever had, had 4 times shingles after the high priced shingles shot. The shingles things were caused from the stress and he/she did not care what they said and stated that the shot did not help at all. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The follow up would not be possible as no contact details were available.
Pt receive vaccine at 11-11:30am. Pat. wife called at 6pm stating that 15 min ago the pat complained of double vision, when both eyes were open. Wife monitored for signs of stroke and no other symptoms.
suspected vaccination failure; flu like symptoms; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a elderly male patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza-like symptoms. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and influenza-like symptoms to be related to Influenza vaccine.  Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient who was over 65, got the regular one flu vaccine and had a slight reaction, flu like symptoms for a couple days but was fine now. This case was considered as suspected vaccination failure as details regarding laboratory test confirmation and time to onset for the event was unknown at the time of reporting. The follow up was not required.
miss 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (miss 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (miss 2nd shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (miss 2nd shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.
suspected vaccination failure; I got the shingles shot and I have had shingles 4 times since; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was reporting for him/herself. The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingles vaccine, the patient had shingles 4 times. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
My whole body is exp shaking movement I went to a Neurologist. I'm still seeing the doctor for the symptoms.
Localized redness and swelling surrounding vaccine administration site 1 day later with itchiness.
Recieved 2 doses of covid vaccine  - 1/6/21 and 2/2/21. Went to ICC reporting: scratchy throat productive cough (yellow mucous), and congestion six days after 2nd dose of vaccine.  Negative COVID PCR on 2/21/21.  Diagnosed with Viral URI with cough.
Patient reports that she has tingling sensation on her feet upon waking up in the morning.   She said that it is going up her legs now.  she has a appointment with her doctor on 12/8 for check up on this adverse event.  She thinks that she may have guillain-barre from the flu shot
No adverse event; Vaqta that underwent a temperature excursion was administered; This spontaneous report has been received from a physician concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.  On 12-AUG-2021, the patient received a dose of Hepatitis A Vaccine, Inactivated (VAQTA), Lot # T033304, expiration date on 02-APR-2022, (dosage information was not provided) that underwent a temperature excursion, for prophylaxis purposes.  The temperature excursion was described as above of 47 Fahrenheit degrees (46.5 F) for 0 hours, 5 minutes, and 0 seconds.  No additional adverse effects or product quality complaints were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: devicelotnumber: T033304; expirationdate: 02-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
itching; "unable to move the neck towards left side"; lots of stiffness on the right arm; pain at left arm near shoulder at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (lots of stiffness on the right arm), PRURITUS (itching), MUSCULOSKELETAL STIFFNESS ("unable to move the neck towards left side") and INJECTION SITE PAIN (pain at left arm near shoulder at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024B21A and 015M30A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BENAZEPRIL for Blood pressure management, ASPIRIN [ACETYLSALICYLIC ACID], FOLIC ACID, LEVOTHYROXINE, DOXAZOSIN MESILATE (DOXAZOCIN), HYDROXYCHLOROQUINE, PREDNISONE and ADALIMUMAB (HUMIRA) for an unknown indication.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced INJECTION SITE PAIN (pain at left arm near shoulder at injection site). On 28-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (lots of stiffness on the right arm) and MUSCULOSKELETAL STIFFNESS ("unable to move the neck towards left side"). On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, MUSCULOSKELETAL STIFFNESS (lots of stiffness on the right arm), PRURITUS (itching), MUSCULOSKELETAL STIFFNESS ("unable to move the neck towards left side") and INJECTION SITE PAIN (pain at left arm near shoulder at injection site) outcome was unknown.            No treatment information was provided by the reporter.   This case was linked to MOD21-059582, MOD-2021-059582 (Patient Link).
possible Sx of Temporal arteritis; left side only- Tenderness,  peri- temporal area; fatigue; Blurry vision; joint pain (bone on bone feeling); This is a spontaneous report from a contactable nurse (patient herself). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6200, expiration date not reported), via an unspecified route of administration, administered in the left arm on 26Feb2021 11:30 (at the age of 68-years-old) as second dose, single dose for COVID-19 immunisation. Relevant medical history included allergy to NSAIDs, cephalosporin, and bee stings, Epstein-Barr virus infection (EBV), chronic obstructive pulmonary disease (COPD), drug induced immune thrombocytopenia (ITP with NSAIDs and Rebetol/Interferon), "T&A", tubal ligation, cholecystectomy, and osteoporosis. Concomitant medications included Zinc, Vit D3, probiotics, and calcium, all taken for an unspecified indication, start and stop dates were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9262, expiration date not reported), via an unspecified route of administration, administered in the left arm on 05Feb2021 15:30 (at the age of 68-years-old) as first dose, single dose for COVID-19 immunisation. After first dose, on an unspecified date in Feb2021, the patient experienced platelets down to 140k, (Hx of drug induced ITP), and splenic discomfort/pain.  Patient also previously received NSAIDs, Interferon and Rebetol and experienced immune thrombocytopenia (drug induced ITP). The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced possible sx of temporal arteritis, left side only- tenderness, peri- temporal area , fatigue, blurry vision, and joint pain (bone on bone feeling) on 28Feb2021 00:00. The patient underwent lab tests and procedures which included platelet count: down to 140k on an unspecified date in Feb2021. Patient waiting on CBC & sediment rate (ESR) bloodwork results. No treatment was received as a result of the events. Patient seek consult of physician as a result of the events. The outcome of all events was not recovered.
patient reported numbness and tingling around lips started the day following the vaccine; reports tongue felt 'burnt' with decreased sensation/sore, scratchy throat and numbness of right cheek into day 7-8 after the vaccine
Pt recieved Zostavax on 4/14/08. Pt states rash developed on face approx 4/28/08. Per wife pt has a red rash with about a dozen pustules on right side of face (temple to chin)with itching. Also has rash under left side of chin. No fever
Patient received mentcra and gardisil. She experienced syncopal episode immediately after getting the gardisal. Menactra was given a minute prior to gardisal. She previously received one dose of the gradisal in the past without reaction. She regained consciousness within 15 seconds of passing out after leg elevation and laying flat. mother and sister were present. She was observed for 15 minutes and sent home with precautions. Advised not to receive any further gardisal vaccines.
Pt is 15 years old, and received the Moderna vaccine which has not yet been approved for children under the age of 18. We checked back with the patient the day of and 2 days after administering the vaccine, and according to her mother she has not experienced any adverse events.
Information has been received from a Registered Nurse (R.N.) concerning an 18 year old female patient with no pertinent medical history and no known drug allergies/drug reactions who on an unspecified date was vaccinated with a dose of GARDASIL (Lot # not reported). There was no concomitant medication reported. It was reported that the patient was vaccinated with GARDASIL during pregnancy. The patient was seen at the practice. On an unspecified date a home pregnancy test and an ultrasound were performed (results not provided). The date of the last menstrual period was on 25-MAR-2009 and the estimated delivery date was 30-DEC-2009. Follow up information was received from a health professional. It was reported that they saw this patient only twice. The first time was in May 2009 and then on 08-JUN-2009 in the emergency room (ER). The patient was seen in the ER due to miscarriage. They have not seen the patients since that time. The reporter mentioned that the patient did not receive the HPV in their office. The patient had reported receiving it in April 2009. Upon internal review, miscarriage was considered to be an other important medical event. No further information is available.
Arm was sore after vaccination. On the 20th I could feel a knot at injection sight. It continued to get bigger and itchy. By the 24 it was much larger knot, red and more itching, by Sunday it was very red and angry looking and was still getting bigger. On Monday, the 26th, I called my doctor he told me to watch it And if I started having adverse actions to go to ER. I called LeFire County Health Department and told them the situation. The nurse said was probably  local reaction and use benedryl, cortisone cream for itching. That evening we took pictures and drew line around the edges, by Tuesday evening it was larger and we marked the outline. It is mot as red or hot today but th knot is going up higher on my arm and it still is very itchy.
Beginning 12 hours after receiving vaccine (3:00am the following night/morning)-  I began waking up in my sleep and felt terrible.   My entire body was aching and any movement at all was painful.  I couldn?t get out of bed.  I couldn?t even roll over.  I ached all over and was completely wiped out.   I took 3 ibuprofen and by 10:00am (20hrs after vaccine), I was able to get out of bed.  Over the next 24-48 hours, I slowly started to feel better but it was a slow and uncomfortable process.  I felt awful!   It took 3 days before I was symptom free.
Dizziness; blurred vision; joint aches; extreme pain; difficulty breathing; fever; chills; sweats; large rash; This is a spontaneous report from a contactable consumer. A non-pregnant 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in the left arm on 21Mar2021 at 15:30 (Batch/Lot Number: EN 62v3) at 37-years-old as a single dose for COVID-19 immunization. The patient did not receive any other vaccine within four weeks of the suspect vaccine.  The patient's medical history included gluten allergy from an unknown date and unknown if ongoing, COVID-19 prior to vaccination from an unknown date and unknown if ongoing. Concomitant medications were not reported. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) for COVID-19 immunization on 28Feb2021 (Lot Number: EN6201, administration time 15:30, location: Left arm, dose number: 1). On 22Mar2021 02:00, the patient experienced: dizziness, blurred vision, joint aches, extreme pain, difficulty breathing, fever, chills, sweats, large rash; all of which required a visit to a doctor or other healthcare professional office/clinic, emergency room/department or urgent care and hospitalization.  The patient was hospitalized for all of the events for 1 day.  The patient underwent lab tests and procedures which included Nasal Swab: negative on 22Mar2021.  Therapeutic measures were taken as a result of the events, which included intravenous (IV) fluids and pain medications. The clinical outcome of the events was recovered with sequelae on an unspecified date.   Follow-up attempts have been completed and no further information is expected.
On 09/24/2000 the patient developed an unknown number of pox. It was noted that it was a mild case and the patient was afebrile. Unspecified medical attention was sought and the patient was diagnosed with atypical varicella. Follow up information from the RN indicated that the patient had multiple lesions and broke out for 10 days. Subsequently on 10/04/2000, the patient recovered. No further information is available.